deoxyglucose has been researched along with Adverse Drug Event in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Albanèse, V; Ballin, A; Defenouillère, Q; García-Rodríguez, FJ; Laussel, C; Léon, S | 1 |
Donohoe, D; Jaggi, U; Rouse, BT; Varanasi, SK | 1 |
2 other study(ies) available for deoxyglucose and Adverse Drug Event
Article | Year |
---|---|
2-deoxyglucose transiently inhibits yeast AMPK signaling and triggers glucose transporter endocytosis, potentiating the drug toxicity.
Topics: AMP-Activated Protein Kinases; Deoxyglucose; Drug-Related Side Effects and Adverse Reactions; Endocytosis; Glucose; Glucose Transport Proteins, Facilitative; Humans; Metabolic Networks and Pathways; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins | 2022 |
Manipulating Glucose Metabolism during Different Stages of Viral Pathogenesis Can Have either Detrimental or Beneficial Effects.
Topics: Animals; Anti-Inflammatory Agents; Cells, Cultured; Cornea; Deoxyglucose; Drug-Related Side Effects and Adverse Reactions; Encephalitis; Female; Glucose; Herpes Simplex; Herpesvirus 1, Human; Inflammation Mediators; Keratitis, Herpetic; Mice; Mice, Inbred C57BL; T-Lymphocyte Subsets; T-Lymphocytes, Regulatory; Virus Replication | 2017 |